Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
464.50    4.90 (1.07%)
Bid:
464.50
Ask:
464.90
Spread: 0.40 (0.086%)
Market Cap: £5.79b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Trading Statement

16 Nov 2023 07:00

RNS Number : 6187T
Melrose Industries PLC
16 November 2023
 

 

16 November 2023

 

MELROSE INDUSTRIES PLC

 

Trading Update

Strong growth, upgrading profit, higher margins

 

 

Melrose Industries PLC ("Melrose") announces the following trading update for the four months from 1 July 2023 to 31 October 2023 ("the Period") and gives upgraded guidance for the 2023 full year and a first guide for 2024. All numbers are calculated at constant currency1.

 

Current trading - better than previous expectations

 

· Melrose is trading ahead of expectations

· Strong revenue growth of 18%2 in the Period, with underlying demand higher

· The margin performance in the Period is substantially better than expectations, driven by higher aftermarket demand and pricing, and the successful delivery of operational improvements

Engines trading in the Period - margins comfortably exceed 25%

 

Engines revenue continues to grow at 18% and adjusted3 operating margins in the Period were comfortably in excess of 25%. This strong performance is driven by good aftermarket trading, up 24% in the Period, from higher volumes, increased scope and positive pricing. Engine OE volumes continue to increase, albeit they are constrained by industry OEM supply chain issues which are ongoing. Given the higher profitability of aftermarket, the resulting business mix is generating stronger margins and this shows no signs of slowing down.

Structures trading in the Period - margins exceed 4%

Revenue growth was 17%2 in the Period and adjusted3 operating margins have risen above 4%, ahead of the previous guidance. This is primarily due to business improvement projects progressing faster than expected. In particular, restructuring benefits from global plant consolidation are coming through and the repricing of contracts is ahead of plan. As a result, the division has positive momentum and is improving the quality of its earnings.

 

New 2023 full year guidance1 - a 7% profit upgrade to previous expectations; stronger margins

 

· Revenue of between £3.3 billion and £3.4 billion

· Aerospace adjusted3 operating profit4 between £400 million and £410 million

· Aerospace adjusted3 operating margin over 12%

· Aerospace adjusted3 EBITDA4 between £545 million and £555 million

 

Expected full year revenue demand and growth continue to be strong at 18%2 year over year. Due to the stronger underlying margins being achieved, the 2023 full year profit expectations are upgraded by 7%, more than doubling profits compared to last year. This reflects ongoing confidence in the performance of the business with Engines full year margins now expected to be 25% and Structures margins 4% or more.

 

Free cashflow5 and net debt, including the share buyback programme which commenced in October, are in line with expectations, with year end leverage3 expected to be c.1.3x.

 

First guide to 20241 - adjusted3 operating profit c.4% better than market expectations6

 

· Revenue of between £3.5 billion7 and £3.7 billion7

· Aerospace adjusted3 operating profit4 between £520 million and £540 million

· Aerospace adjusted3 operating margin c.15%

· Aerospace adjusted3 EBITDA4 between £680 million and £700 million

 

The first guide to 2024 adjusted3 operating profit performance is c.4% better than market expectations6 even whilst prudently assuming that demand will continue to be constrained by supply. Growth will become higher when these ease. In addition, significant operational improvements are on track in both Engines and Structures to enhance margins further.

 

Including the cash impact arising from the recent announcements about the GTF Engine, ongoing restructuring spend, and the announced £500 million share buyback programme, Melrose expects leverage3 in 2024 to be comfortably below 2x, better than the previous medium term leverage guidance.

 

These higher expectations for 2023 and 2024 announced today, along with the recent signing of the new GE deal announced on 6 November 2023, show the guidance given in the Capital Markets Event on 17 May 2023 is being exceeded and the stated 2025 profit targets are substantially more underpinned than before.

 

 

Simon Peckham, Chief Executive of Melrose said:

 

"It is a pleasure to hand over Melrose so well positioned for the future. 2024 will be another year of strong progress under its new leadership as the targets announced in the Capital Markets Event come into sight."

 

 

1. Calculated using a foreign exchange rate of £1 = US$1.25

2. Excluding revenue from planned site closures

3. Described in the glossary to the Melrose Industries PLC Interim Financial Statements and considered by the Board to be a key measure of performance

4. Excluding PLC central costs

5. Free cashflow, post-central costs but before interest and tax

6. Per company compiled consensus of twelve analysts, being £510 million adjusted3 operating profit for 2024

7. After exiting c.£150 million of sales as planned, over the period from the Capital Markets Event on 17 May 2023 to the end of 2024

 

-ends-

 

 

 

Enquiries:

Investor Relations: Chris Dyett +44 (0) 7974 974690

ir@melroseplc.net

 

Montfort Communications: +44 (0) 20 3514 0897

Nick Miles +44 (0) 7739 701634 / Charlotte McMullen +44 (0) 7921 881800

miles@montfort.london / mcmullen@montfort.london

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBELLFXFLBFBV
Date   Source Headline
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20246:25 pmRNSDirector Declaration
19th Sep 202412:30 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSAppointment of Independent Non-Executive Director
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20249:30 amRNSHolding(s) in Company
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20245:55 pmRNSHolding(s) in Company
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 202412:20 pmRNSDirector/PDMR Shareholding
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 202411:01 amRNSDirector/PDMR Shareholding
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSHalf-year Report
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.